Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.1K
Overview
85.1K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redesigning healthcare: an interview with Dr Fei-chau Pang.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Outcomes after right-sided colon surgery in Crohn's disease versus cancer.

Techniques in coloproctology·2024
Same author

Magnon gap excitations in van der Waals antiferromagnet MnPSe<sub>3</sub>.

Scientific reports·2024
Same author

Robotic abdominoperineal resection for T4b rectal cancer using the da Vinci SP platform.

Techniques in coloproctology·2023
Same author

The use of botulinum toxin in the acute management of symptomatic complex incisional hernia: a case series.

Hernia : the journal of hernias and abdominal wall surgery·2023
Same author

Disposable versus reusable fibre-optic nasendoscopes: a national survey of UK ENT surgical trainees and a single-centre cost-analysis.

The Journal of laryngology and otology·2022

Related Experiment Video

Updated: Mar 1, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

4.0K

Major Histocompatibilty Complex-Restricted Adaptive Immune Responses to CT26 Colon Cancer Cell Line in Mixed

K W Lee1, B Choi2, Y M Kim3

  • 1Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Transplantation Research Center, Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Transplantation Proceedings
|June 7, 2017
PubMed
Summary

Mixed allogeneic chimeras enhance anti-cancer immunity. This study shows that these chimeric environments sustain both primary and memory T-cell responses against tumors, suggesting potential for cancer therapy.

More Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

10.4K
Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
09:48

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E

Published on: September 26, 2019

16.8K

Related Experiment Videos

Last Updated: Mar 1, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

4.0K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

10.4K
Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
09:48

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E

Published on: September 26, 2019

16.8K

Area of Science:

  • Immunology
  • Oncology
  • Transplantation

Background:

  • Mixed allogeneic chimera induction shows promise in organ transplantation tolerance.
  • The anti-cancer therapeutic potential of mixed allogeneic chimeras remains unexplored.

Purpose of the Study:

  • To investigate the clinical relevance of mixed allogeneic chimeras as an anti-cancer therapy.
  • To analyze anti-cancer T-cell responses and T-cell subpopulations in a murine colon cancer model.

Main Methods:

  • Established a mixed allogeneic chimera model using double bone marrow transplantation in mice.
  • Administered CT26 colon cancer cells and analyzed cancer-specific CD4+ and CD8+ T-cell responses via flow cytometry using specific pentamers.

Main Results:

  • Tumor immunity relies on major histocompatibility complex-restricted, cancer-specific CD8+ T-cell responses, supported by increased interferon-γ-secreting CD4+ T cells.
  • Both central and effector memory T cells were present during the anti-cancer immune response.
  • Mixed allogeneic chimeras exhibited comparable or enhanced immune responses to CT26 cancer compared to wild-type mice.

Conclusions:

  • Mixed allogeneic chimeric environments effectively sustain and preserve long-term immune responses against allogeneic cancer.
  • This suggests a potential role for mixed allogeneic chimeras in bolstering anti-cancer immunity.